HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Tifluadom, a benzodiazepine with opioid-like activity: study of its central mechanism of action in conscious dogs].

Abstract
A derivative of the 1,4-benzodiazepine series with reported opioid activity was evaluated in regard to its effect on central nervous activity in the awake canine. Additionally a possible benzodiazepine- or opioid-receptor interaction was evaluated by using specific antagonists. In 10 experiments increasing doses of tifluadom (5, 10, 20, 40, 80 micrograms/kg) modified somato-sensory-evoked potentials (SEP) inducing a dose-related latency change (40-80 micrograms/kg) and a suppression (80 micrograms/kg) of the P50-peak. Both effects are interpreted as a modification of stimuli reaching the somatosensory cortex. EEG-spectral analysis was characterized by a dose-related decrease of power in the higher frequency range (13-40 Hz) accompanied by an increase of power in the lower band (0.5-3.5 Hz). This effect was paralleled by deep sedation. The specific benzodiazepine antagonist Ro 15-1788 (240 micrograms/kg) was ineffective in reversing central nervous EEG- and SEP-changes. Naloxone (20 micrograms/kg) induced a short-term (5 min) arousal and a partial reversal of SEP-changes. The specific opioid-kappa-antagonist Mr 2266 (20 micrograms/kg) however, induced a long lasting return of power spectra and SEP-changes back to control. This results suggest that tifluadom, although being structurally a benzodiazepine, interacts with an opioid sub-receptor of the kappa-type, which is known to induce sedation and supraspinal analgesia without respiratory depression.
AuthorsM Schaal, E Freye, R Windelschmidt
JournalEEG-EMG Zeitschrift fur Elektroenzephalographie, Elektromyographie und verwandte Gebiete (EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb) Vol. 17 Issue 1 Pg. 27-31 (Mar 1986) ISSN: 0012-7590 [Print] Germany
Vernacular TitleTifluadom, ein Benzodiazepin mit opioidartigem Wirkcharakter: Eine Untersuchung zum zentralen Wirkmechanismus an wachen Hunden.
PMID3084201 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Benzodiazepinones
  • Benzomorphans
  • Benzodiazepines
  • Naloxone
  • Flumazenil
  • MR 2266
  • tifluadom
Topics
  • Animals
  • Benzodiazepines (antagonists & inhibitors, pharmacology)
  • Benzodiazepinones (pharmacology)
  • Benzomorphans (pharmacology)
  • Brain (drug effects)
  • Dogs
  • Dose-Response Relationship, Drug
  • Electroencephalography
  • Evoked Potentials, Somatosensory (drug effects)
  • Flumazenil
  • Naloxone (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: